Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
3 other identifiers
interventional
203
1 country
1
Brief Summary
This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Primary care provider visits in these communities serve as a crucial opportunity to communicate the importance of timely vaccination that is essential to effective cancer prevention. This study implements and tests a practice-level intervention (PC TEACH) using practice facilitation of evidence-based strategies to expand reach to rural community-based primary care settings to optimize delivery and increase HPVV rates. PC TEACH program may help rural communities overcome access and awareness factors that keep them from receiving HPVV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 24, 2023
CompletedFirst Submitted
Initial submission to the registry
February 2, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
March 17, 2026
March 1, 2026
3.9 years
February 2, 2024
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Adolescent HPV vaccination rates
To evaluate the impact (short and long-term) of the proposed PC TEACH (primary care practice-level, medical office-based intervention) intervention on human papilloma virus vaccine (HPVV) uptake and completion rates using a staggered (stepped-wedge) intervention schedule. Briefly, practice-specific vaccine rates data will be modeled as a function of time in intervention (0, 6, 12, 18, or 24 months), while adjusting for baseline rates collected prior to intervention for each practice. For vaccine rates, an additional factor for calendar time will be included in the model to address potential seasonal effects.
Up to 5 years (60 months)
Secondary Outcomes (1)
Age at vaccination
Up to 5 years (60 months)
Study Arms (1)
Health services research (PC TEACH)
OTHERPrimary practice providers sites receive PC TEACH over 3.5 hours for 12 months
Interventions
Evidence-based strategy (PC TEACH)
Eligibility Criteria
You may qualify if:
- PRACTICES: Are located in the 20-county target region
- PRACTICES: Have an adolescent patient population \>= 150 (aged 9-18)
- PRACTICES: Administer adolescent vaccines (e.g., HPV, Tdap, MCV4)
- PRACTICES: Are willing to share aggregate practice and patient-level data (e.g., electronic health record \[EHR\], surveys)
- PARTICIPANTS: Medical providers and medical staff \>= 18 years of age
- PARTICIPANTS: Primary care providers and medical office staff who deliver adolescent care at community-based primary care practice sites across 20 rural counties in central and western New York
- PARTICIPANTS: Age \>= 18 years of age (no upper limit)
- PARTICIPANTS: English speaking
- PARENT/GUARDIAN SURVEY: Adult accompanying a child or children aged 9 to 17
- PARENT/GUARDIAN SURVEY: English speaking
- PARENT/GUARDIAN SURVEY: Presenting to the participating clinic for an outpatient well child visit or regular checkup
- PARENT/GUARDIAN SURVEY: Willing to complete an anonymous survey while visiting the clinic
You may not qualify if:
- Unwilling or unable to follow protocol requirements
- Adults unable to complete study measures in English
- Individuals who are not yet adults (infants, children, teenagers)
- Cognitively impaired adults/adults with impaired decision-making capacity
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisa Rodriguez
Roswell Park Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2024
First Posted
February 13, 2024
Study Start
May 24, 2023
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
March 17, 2026
Record last verified: 2026-03